0000000000642454

AUTHOR

R. Di Trapani

showing 3 related works from this author

Rituximab for managing relapsing or refractory patients with idiopathic thrombotic thrombocytopenic purpura – haemolytic uraemic syndrome

2010

AdultMaleSalvage TherapyAdolescentPurpura Thrombotic ThrombocytopenicADAMTS13 ProteinCase ReportMiddle AgedADAM ProteinsAntibodies Monoclonal Murine-DerivedTreatment OutcomeHumansImmunologic FactorsFemaleRituximabrefractory thrombotic thrombocytopenic purpura
researchProduct

Are blood donors an adequate control group to ascertain HCV prevalence in non-Hodgkin’s lymphoma patients?

2002

Blood donorSettore MED/09 - Medicina Internanon-Hodgkin’s lymphomaHCV prevalence
researchProduct

Relapsing or refractory idiopathic thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: the role of rituximab.

2010

thrombotic thrombocytopenic purpura rituximab
researchProduct